Pharmaceutical Executive September 12, 2024
The latest news for pharma industry insiders.
Regulatory CMC: Enhancing Biologics Development
Preventing delays and accelerating the progression of these critical therapies.
Study Finds Cap on Out-of-Pocket Costs Saves Cancer Patients $7,000
The Inflation Reduction Act’s limit on Medicare Part D spending can lead to savings for patients prescribed oral chemotherapy drugs.
AI Will Force a Transformation of Tech Infrastructure
Corporate technology executives need to ensure their cloud and private infrastructure is ready to handle their data needs to come.
FDA Grants Clearance for Immunis’ Phase II Sarcopenic Obesity Trial
Immunis, Inc. was recently granted permission by the FDA to proceed with its Phase II clinical trial testing its investigational secretome (IMMUNA) in...
Today's Sponsors
Today's Sponsor